Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
discussing flexible working arrangements. Are you an ambitious researcher with expertise in plant proteins, food or feed science, and in vitro digestion? Do you want to apply advanced analytical methods to
-
test articles, in vivo sample collection, in vivo imaging, euthanasia and post mortem sample collection. In vitro and ex vivo processing of tissue samples. Execute in vitro assays to evaluate immune data
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 20 hours ago
sustained impact, as articulated in the School’s Strategic Plan (https://pharmacy.unc.edu/about/oe/strategic-plan/). Our Vision is to be the global leader in pharmacy and pharmaceutical sciences. Our
-
data. Manage preferences for further information and to change your choices. Accept all cookies Reject optional cookies Skip to main content Senior Scientist, In Vitro Toxicology Employer Orion
-
in vitro experiments and the use of new therapeutic molecules (cell biology, molecular biology, chemical synthesis, etc.) as well as animal studies (imaging and therapy). Where to apply Website https
-
independently conduct the characterization of autoantibodies in patients with PLA2R1-associated membranous nephropathy, from molecular characterization through in vitro and in vivo studies. Produce various
-
, with an emphasis on technology, data science and the humanities. The Molecular and Cellular Dysfunction in Diabetes Laboratory, led by Associate Professor Yusuf Ali, combines in vitro systems biology
-
basic research projects i) investigating of the role of phosphoinositide 3-kinase (PI3K) signaling in allergy, metabolic control, obesity, diabetes and cancer; see https://data.snf.ch/grants/grant
-
the thesis will investigate the biological response in vitro, including cell adhesion and proliferation, using different cell types. In parallel, part of the project will focus on investigating the
-
be developing novel, radiometal- and peptide-based radiopharmaceuticals for the diagnosis (nuclear imaging) and therapy of cancer (theranostics). The novel compounds will be assessed first in vitro